RT @Sydenhamnotes: #Cardiology Beta bloqueadores en falla cardiaca y enfermedad coronaria. En SCA todavía falta que se sedimente la evidenc…
MS2 - Table source and a lot more info (optional) found here: https://t.co/i91l5o3AwA
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5). https://t.co/kypkEehKyF
RT @Sydenhamnotes: #Cardiology Beta bloqueadores en falla cardiaca y enfermedad coronaria. En SCA todavía falta que se sedimente la evidenc…
RT @Sydenhamnotes: #Cardiology Beta bloqueadores en falla cardiaca y enfermedad coronaria. En SCA todavía falta que se sedimente la evidenc…
RT @Sydenhamnotes: #Cardiology Beta bloqueadores en falla cardiaca y enfermedad coronaria. En SCA todavía falta que se sedimente la evidenc…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
RT @_AnaDelRio_: Uso de B-bloqueantes en Insuficiencia cardiaca y enfermedad coronaria #JACCJournals https://t.co/a2rDeEawPc
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) https://t.co/Xki5ZeKIW9
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
RT @krychtiukmd: Interesting series in @JACCJournals on pharmacological agents in cardiovascular care - first chapter is on betablockers…
【総説】冠動脈疾患および心不全におけるβ遮断薬の進化 https://t.co/vMcDK1Hdym
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
なんかこのシリーズが3つしか見当たらないんですが、 とりあえず共有します。Part1は心不全とIHDのβです。 REDUCE-SWEDEHEARTとか知らなかった。。。 The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) https://t.co/rNvIC4Ogkg
RT @boback: Nice Series:The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) | JACC: Journal of the American…
Nice Series:The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) | JACC: Journal of the American College of Cardiology https://t.co/R7uAKk5kU6
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
Nice general overview of BB use in HF and CAD https://t.co/LBL6PGE6o9 @JACCJournals @coconnormd
RT @gonzaeperez: BETABLOQUEANTES EN INSUFICIENCIA CARDÍACA Y ENFERMEDAD CORONARIA -#HFrEF Beneficio claro -#HFpEF #HFmEF No hay evidencia…
RT @PHRIresearch: .@PHRIresearch's Philip Joseph (1st author), coauthors include #PHRI's @DarrylLeong and Salim Yusuf: The Evolution of β-B…
.@PHRIresearch's Philip Joseph (1st author), coauthors include #PHRI's @DarrylLeong and Salim Yusuf: The Evolution of β-Blockers in #CoronaryArteryDisease and #HeartFailure (Part 1/5) https://t.co/ZCI7b3UeIX in @JACCJournals
A good review for #accfit https://t.co/kmhYBdSyGT
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @igormorr: GOOD REVIEW OF THE MEDICINES THAT BLOCK BETA ADRENERGIC RECEPTORS: HISTORICALLY A REDUCTION OF GENERAL AND CARDIOVASCULAR MOR…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @StefaniaArciell: The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) https://t.co/trABvE7W3w
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) https://t.co/trABvE7W3w
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @igormorr: GOOD REVIEW OF THE MEDICINES THAT BLOCK BETA ADRENERGIC RECEPTORS: HISTORICALLY A REDUCTION OF GENERAL AND CARDIOVASCULAR MOR…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @igormorr: GOOD REVIEW OF THE MEDICINES THAT BLOCK BETA ADRENERGIC RECEPTORS: HISTORICALLY A REDUCTION OF GENERAL AND CARDIOVASCULAR MOR…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @igormorr: GOOD REVIEW OF THE MEDICINES THAT BLOCK BETA ADRENERGIC RECEPTORS: HISTORICALLY A REDUCTION OF GENERAL AND CARDIOVASCULAR MOR…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @igormorr: GOOD REVIEW OF THE MEDICINES THAT BLOCK BETA ADRENERGIC RECEPTORS: HISTORICALLY A REDUCTION OF GENERAL AND CARDIOVASCULAR MOR…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @igormorr: GOOD REVIEW OF THE MEDICINES THAT BLOCK BETA ADRENERGIC RECEPTORS: HISTORICALLY A REDUCTION OF GENERAL AND CARDIOVASCULAR MOR…
RT @IEgocheaga: ¿Revisamos los tratamientos crónicos con betabloqueantes? https://t.co/S3csP0Uuz3
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @igormorr: GOOD REVIEW OF THE MEDICINES THAT BLOCK BETA ADRENERGIC RECEPTORS: HISTORICALLY A REDUCTION OF GENERAL AND CARDIOVASCULAR MOR…
RT @igormorr: GOOD REVIEW OF THE MEDICINES THAT BLOCK BETA ADRENERGIC RECEPTORS: HISTORICALLY A REDUCTION OF GENERAL AND CARDIOVASCULAR MOR…
GOOD REVIEW OF THE MEDICINES THAT BLOCK BETA ADRENERGIC RECEPTORS: HISTORICALLY A REDUCTION OF GENERAL AND CARDIOVASCULAR MORTALITY FROM 20 to 49%. FIGURE NOT NEGLIGIBLE...@mencardio @ernestocardio @MiSaludTotal @meza0208 https://t.co/QIKw4VNR1h
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
I love me some beta blockers! This is a great review focusing on which clinical settings to use beta blockers with good evidence. Surprising to me was the section on BB after MI (question 2). #medtwitter #FOAMed #cardiotwitter #acc #HeartFailure #hfref #h
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
RT @JACCJournals: ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types o…
@JACCJournals The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) https://t.co/DeFaVkKQmO https://t.co/gzx0d6Fmpi
ICYMI: This #JACC State-of-the-Art Review provides a look at the evolution β-blockers and their importance in all types of #heartfailure and #cvCAD. https://t.co/UBXHR7KxNT https://t.co/brM3TLhk1K
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5). https://t.co/RBUuuecn0v
Uso de B-bloqueantes en Insuficiencia cardiaca y enfermedad coronaria #JACCJournals
Recomendaciones del uso de B bloqueadores en ICC y Enf Coronaria. https://t.co/0uvo0aSdj5
RT @IEgocheaga: ¿Revisamos los tratamientos crónicos con betabloqueantes? https://t.co/S3csP0Uuz3
RT @IEgocheaga: ¿Revisamos los tratamientos crónicos con betabloqueantes? https://t.co/S3csP0Uuz3
RT @IEgocheaga: ¿Revisamos los tratamientos crónicos con betabloqueantes? https://t.co/S3csP0Uuz3
RT @IEgocheaga: ¿Revisamos los tratamientos crónicos con betabloqueantes? https://t.co/S3csP0Uuz3
¿Revisamos los tratamientos crónicos con betabloqueantes?
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @Derek_Leong_RPh: Great review of the evidence for use of beta blockers in HFrEF, HFpEF & HFmEF, ACS and stable CAD. https://t.co/ciSYwH…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…
RT @ATRIUMRx: Nice @JACCJournals review of beta blockers in the management of CVD. If you'd like to take a stroll through history, check ou…
RT @JACCJournals: #JACC State-of-the-Art Review: When is it appropriate to use β-blockers in #heartfailure and #CHD patients? This week's i…